Acura Pharmaceuticals, Inc. is a drug delivery company, which engages in the research, development, and commercialization of technologies and products intended to address safe use of medications. The company is headquartered in Palatine, Illinois. The company went IPO on 2000-09-12. Its platform technologies include LIMITX Technology, AVERSION Technology, and IMPEDE Technology. Its LIMITX Technology is designed to minimize the risks and side effects associated with overdose by retarding the release of active drug ingredients when too many tablets are accidentally or purposefully ingested. The LIMITX Technology is in development with hydrocodone bitartrate and acetaminophen (also known as LTX-03) as the lead product candidates. Its AVERSION Technology is to address methods of product tampering associated with opioid abuse by incorporating gelling ingredients and irritants into tablets to discourage abuse by snorting and provide barriers to abuse by injection. Its IMPEDE Technology is directed at minimizing the extraction and conversion of pseudoephedrine tablets into methamphetamine.
Based on 7 analysts giving stock ratings to ACUR, updated on Dec 01, 2021
Buy
Strong buy
2
Buy
4
Hold
1
Sell
0
Strong sell
0
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for ACUR. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: ACUR is a Buy candidate.
ACUR stock price ended at $0 on Monday, after rising NaN%
On the latest trading day Jan 12, 2026, the stock price of ACUR rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 9 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 200 shares were traded, equating to a market value of approximately --.
ACUR Technical Signals
Technical Signals Summary
Buy Signals 1
Neutral Signals 6
Sell Signals 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
ACUR currently exhibits 1 buy signals and 0 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of -- during this period. Overall, the technical indicators point to a Buy outlook for the mid-term.
Bullish/Bearish Signals for ACUR
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for ACUR. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to ACUR?
What are the Fibonacci retracement levels for ACUR?
What is the RSI for Acura Pharmaceuticals Inc?
What is Acura Pharmaceuticals Inc price for the next 12 months?
How high is Acura Pharmaceuticals Inc expected to go?